Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2351649rdf:typepubmed:Citationlld:pubmed
pubmed-article:2351649lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:2351649lifeskim:mentionsumls-concept:C0032105lld:lifeskim
pubmed-article:2351649lifeskim:mentionsumls-concept:C0028630lld:lifeskim
pubmed-article:2351649lifeskim:mentionsumls-concept:C0017337lld:lifeskim
pubmed-article:2351649lifeskim:mentionsumls-concept:C0678226lld:lifeskim
pubmed-article:2351649lifeskim:mentionsumls-concept:C0052181lld:lifeskim
pubmed-article:2351649lifeskim:mentionsumls-concept:C0032529lld:lifeskim
pubmed-article:2351649lifeskim:mentionsumls-concept:C1706204lld:lifeskim
pubmed-article:2351649lifeskim:mentionsumls-concept:C1555721lld:lifeskim
pubmed-article:2351649pubmed:issue17lld:pubmed
pubmed-article:2351649pubmed:dateCreated1990-7-16lld:pubmed
pubmed-article:2351649pubmed:abstractTextGenetic polymorphism of human plasma apolipoprotein A-IV has been detected by isoelectric focusing techniques followed by immunoblotting. The molecular basis for this apoA-IV polymorphism has been elucidated. Analysis of the protein coding sequences of the apoA-IV alleles 1 and 2 revealed a single G to T substitution in the apoA-IV-2 allele. The point mutation, occurring in a region highly conserved among the mouse, rat, and human A-IV apolipoproteins, converts the glutamine at position 360 of the mature protein to a histidine. This amino acid substitution adds one positive charge unit to the apoA-IV-1 isoprotein (pI 4.97) thus creating the more basic apoA-IV-2 isoprotein (pI 5.02). Computer analysis of the apoA-IV-2 allele revealed that the single G to T substitution results in the loss of a BbvI and a Fnu4HI restriction enzyme site and in the formation of a new restriction site for the enzyme SfaNI. Protein primary and secondary structure predictions were largely unaffected by this amino acid exchange. These results on the structure of the apoA-IV-1 and apoA-IV-2 alleles suggest that the three other rare isoproteins (apoA-IV-0, apoA-IV-3, and apoA-IV-4) are also due to nucleotide and subsequent amino acid substitutions in the apoA-IV sequence.lld:pubmed
pubmed-article:2351649pubmed:languageenglld:pubmed
pubmed-article:2351649pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2351649pubmed:citationSubsetIMlld:pubmed
pubmed-article:2351649pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2351649pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2351649pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2351649pubmed:statusMEDLINElld:pubmed
pubmed-article:2351649pubmed:monthJunlld:pubmed
pubmed-article:2351649pubmed:issn0021-9258lld:pubmed
pubmed-article:2351649pubmed:authorpubmed-author:BrewerH BHBJrlld:pubmed
pubmed-article:2351649pubmed:authorpubmed-author:LohsePPlld:pubmed
pubmed-article:2351649pubmed:authorpubmed-author:RaderD JDJlld:pubmed
pubmed-article:2351649pubmed:authorpubmed-author:KindtM RMRlld:pubmed
pubmed-article:2351649pubmed:issnTypePrintlld:pubmed
pubmed-article:2351649pubmed:day15lld:pubmed
pubmed-article:2351649pubmed:volume265lld:pubmed
pubmed-article:2351649pubmed:ownerNLMlld:pubmed
pubmed-article:2351649pubmed:authorsCompleteYlld:pubmed
pubmed-article:2351649pubmed:pagination10061-4lld:pubmed
pubmed-article:2351649pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2351649pubmed:meshHeadingpubmed-meshheading:2351649-...lld:pubmed
pubmed-article:2351649pubmed:meshHeadingpubmed-meshheading:2351649-...lld:pubmed
pubmed-article:2351649pubmed:meshHeadingpubmed-meshheading:2351649-...lld:pubmed
pubmed-article:2351649pubmed:meshHeadingpubmed-meshheading:2351649-...lld:pubmed
pubmed-article:2351649pubmed:meshHeadingpubmed-meshheading:2351649-...lld:pubmed
pubmed-article:2351649pubmed:meshHeadingpubmed-meshheading:2351649-...lld:pubmed
pubmed-article:2351649pubmed:meshHeadingpubmed-meshheading:2351649-...lld:pubmed
pubmed-article:2351649pubmed:meshHeadingpubmed-meshheading:2351649-...lld:pubmed
pubmed-article:2351649pubmed:meshHeadingpubmed-meshheading:2351649-...lld:pubmed
pubmed-article:2351649pubmed:meshHeadingpubmed-meshheading:2351649-...lld:pubmed
pubmed-article:2351649pubmed:meshHeadingpubmed-meshheading:2351649-...lld:pubmed
pubmed-article:2351649pubmed:meshHeadingpubmed-meshheading:2351649-...lld:pubmed
pubmed-article:2351649pubmed:meshHeadingpubmed-meshheading:2351649-...lld:pubmed
pubmed-article:2351649pubmed:meshHeadingpubmed-meshheading:2351649-...lld:pubmed
pubmed-article:2351649pubmed:meshHeadingpubmed-meshheading:2351649-...lld:pubmed
pubmed-article:2351649pubmed:year1990lld:pubmed
pubmed-article:2351649pubmed:articleTitleGenetic polymorphism of human plasma apolipoprotein A-IV is due to nucleotide substitutions in the apolipoprotein A-IV gene.lld:pubmed
pubmed-article:2351649pubmed:affiliationMolecular Disease Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892.lld:pubmed
pubmed-article:2351649pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2351649pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:2351649pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:337entrezgene:pubmedpubmed-article:2351649lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2351649lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2351649lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2351649lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2351649lld:pubmed